Last week, a group of senators re-introduced a measure to promote studies on the use of marijuana by veterans. It is expected that an identical bill will be introduced in the House in the near-term.
A congressional source has revealed that the measure’s introduction in the House maximizes the likelihood of its passage through both chambers.
The bipartisan measure in question, the VA Medicinal Cannabis Research Act, directs that the U.S. Veterans Affairs’ department look into the medical potential of cannabis for military veterans, in particular those who suffer from chronic pain and post-traumatic stress disorder. The measure was sponsored by chair Jon Tester of the Senate Veterans’ Affairs Committee and Senator Dan Sullivan. This resolution was carried in previous sessions by Representative Lou Correa.
Sullivan added that they had an obligation to better understand and explore new remedies for mental health conditions that were both effective and safe, and could offer veterans some hope.
Despite protests from VA officials, an earlier version of this resolution was advanced by a House committee. Other versions moved through committee in 2018 and 2020. However, none of these was enacted into law.
The older versions directed that clinical trials evaluating the therapeutic potential of marijuana in the treatment of chronic pain and PTSD be carried out. This is slightly different from the most recent version, which was revised to also include a requirement for a retroactive observation study on the experiences of veterans who have used cannabis for such treatment previously, outside of the clinical trail context.
Other amendments to the bill’s new version include the removal of language that directed studies to use no less than seven marijuana varieties. This comes after an alliance of veterans’ service organizations penned a letter to congressional leaders last year requesting that they approve a cannabis and veterans research legislation before the end of the session. This action was unsuccessful.
As more states revise their drug laws, a larger market will potentially open not just for “plant-touching” companies but also ancillary companies that focus on addressing the needs of the cannabis companies, such as Advanced Container Technologies Inc. (OTC: ACTX).
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.